Clinical trial
R(+)XK469 in Treating Patients With Advanced Neuroblastoma
NCT00028522 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00028522 |
|---|---|
| Title | R(+)XK469 in Treating Patients With Advanced Neuroblastoma |
| Official title | Phase I Study Of R(+)XK469 In Patients With Advanced Neuroblastoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Disseminated Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma, Regional Neuroblastoma |
| Intervention type | Drug |
| Interventions | R(+)XK469 |
| Enrollment | 85 |
| Start date | Dec 1, 2001 |
| Primary completion | Sep 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: